ALB and cancer: Similar to peripheral blood-based biomarkers derived from blood count, albumin levels are significantly affected by inflammatory pressure (Soeters et al., 2019), and lower albumin levels are seen in cases of chronic inflammatory disorders and cancer as a negative acute phase reactant (Fiala et al., 2016; Schneider et al., 2022).